Hsu Jason has filed 10 insider transactions across 1 company since May 2024.
Most recent transaction: a grant/award of 33000 shares of Immix Biopharma, Inc. ($IMMX) on June 20, 2025.
Activity breakdown: 6 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 20, 2025 | Immix Biopharma, Inc. | $IMMX | Hsu Jason | Director | A | Stock Option (Right to Buy) | 33000 | $0.00 | 33,000.0000 | 27,722,108 | 9999.99% | 0.12% |
| Dec. 20, 2024 | Immix Biopharma, Inc. | $IMMX | Hsu Jason | Director | P | Common Stock | 7700 | $2.17 | 4,818,913.0000 | 0 | 0.16% | 0.00% |
| Dec. 23, 2024 | Immix Biopharma, Inc. | $IMMX | Hsu Jason | Director | P | Common Stock | 40000 | $2.19 | 4,858,913.0000 | 0 | 0.83% | 0.00% |
| Aug. 21, 2024 | Immix Biopharma, Inc. | $IMMX | Hsu Jason | Director | P | Common Stock | 15000 | $2.23 | 4,803,113.0000 | 0 | 0.31% | 0.00% |
| Aug. 22, 2024 | Immix Biopharma, Inc. | $IMMX | Hsu Jason | Director | P | Common Stock | 8100 | $2.25 | 4,811,213.0000 | 0 | 0.17% | 0.00% |
| July 18, 2024 | Immix Biopharma, Inc. | $IMMX | Hsu Jason | Director | P | Common Stock | 3200 | $2.07 | 4,782,113.0000 | 0 | 0.07% | 0.00% |
| July 24, 2024 | Immix Biopharma, Inc. | $IMMX | Hsu Jason | Director | P | Common Stock | 6000 | $2.15 | 4,788,113.0000 | 0 | 0.13% | 0.00% |
| June 11, 2024 | Immix Biopharma, Inc. | $IMMX | Hsu Jason | Director | A | Stock Option (Right to Buy) | 33000 | $0.00 | 33,000.0000 | 0 | 9999.99% | 0.00% |
| May 15, 2024 | Immix Biopharma, Inc. | $IMMX | Hsu Jason | Director | A | Stock Option (Right to Buy) | 21587 | $0.00 | 21,587.0000 | 0 | 9999.99% | 0.00% |
| May 15, 2024 | Immix Biopharma, Inc. | $IMMX | Hsu Jason | Director | A | Stock Option (Right to Buy) | 25512 | $0.00 | 25,512.0000 | 0 | 9999.99% | 0.00% |